Advertisement
News
Subscribe to MDT Magazine News

Omeros to Present at the BioCentury NewsMakers Conference

October 15, 2010 5:32 am | by Bio-Medicine.Org | Comments

SEATTLE, Oct. 15 /- Omeros Corporation (Nasdaq: OMER ), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief...

TOPICS:

Mylan Receives Approvals for Generic Versions of Hyzaar® and Cozaar®

October 15, 2010 4:31 am | by Bio-Medicine.Org | Comments

PITTSBURGH, Oct. 15 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approvals from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for the generic versions of Hyzaar® Tablets, 50...

TOPICS:

Southeastern Michigan Gets First Ever FDA Approved Device That Destroys Fat Cells ... Without Surgery

October 15, 2010 3:31 am | by Bio-Medicine.Org | Comments

SHELBY TOWNSHIP, Mich., Oct 14 /- Allure Medical Spa, first in Michigan with the new FDA approved Coolsculpting™ by Zeltiq. Great news for men and women dealing with exercise and diet-resistant fat in areas like the tummy, love handles and back rolls! Allure Medical Spa of Shelby...

TOPICS:
Advertisement

Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients

October 15, 2010 1:32 am | by Bio-Medicine.Org | Comments

Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients -- PARIS, October 15, 2010 /-

TOPICS:

Kibbutz Shamir and Essilor Sign Agreement

October 15, 2010 1:32 am | by Bio-Medicine.Org | Comments

Kibbutz Shamir and Essilor Sign Agreement -- KIBBUTZ SHAMIR, Israel and CHARENTON-LE-PONT, France, Oct. 15 /-

TOPICS:

Cellectis Publishes Its Financial Statement for the First Half of 2010

October 15, 2010 1:31 am | by Bio-Medicine.Org | Comments

PARIS, Oct. 15 /- Cellectis (Alternext: ALCLS), the French genome engineering specialist, today published its consolidated financial statement for the half-year ending June 30, 2010: revenues increased 25% over H1 2009, expenditure increased 50% and the company ended the period with euro...

TOPICS:

CryoLife Announces Release Date and Teleconference Call Details for 2010 Third Quarter Financial Results

October 14, 2010 6:32 pm | by Bio-Medicine.Org | Comments

ATLANTA, Oct. 14 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, announced today that 2010 third quarter financial results will be released on Thursday, November 4, 2010.  On that day, the Company will hold a...

TOPICS:

Henry Schein to buy Provet Holdings for $91M

October 14, 2010 5:45 pm | by The Associated Press | Comments

Henry Schein Inc. said Thursday it has agreed to buy Australian veterinary products distributor Provet Holdings Ltd. In a cash-for-stock deal valued at $91 million.Under the terms of the deal, Henry Schein will pay Provet shareholders $2.12 for each outstanding share, representing a premium of...

Advertisement

DFG establishes 4 new research units

October 14, 2010 12:33 pm | by EurekAlert | Comments

(Deutsche Forschungsgemeinschaft) The Deutsche Forschungsgemeinschaft is establishing four new research units to facilitate cross-regional, interdisciplinary cooperation among researchers.

TOPICS:

Janam Introduces Mobile Healthcare Product Line

October 14, 2010 12:32 pm | by Bio-Medicine.Org | Comments

WOODBURY, N.Y., Oct. 14 /- Janam Technologies LLC, a leading provider of rugged mobile computers that scan barcodes and communicate wirelessly, today announced a new mobile healthcare solution that extends the company's popular XM Series product line with antimicrobial versions of the...

TOPICS:

Federal Government Selects Thomson Reuters to Build Tool That Streamlines Comparative Effectiveness Research

October 14, 2010 12:32 pm | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., Oct. 14 /- The U.S. Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE) has selected Thomson Reuters to develop a secure, interactive tool that will enable researchers to perform comparative effectiveness studies without the need for...

TOPICS:

FDA Issues Warnings to Marketers of Unapproved 'Chelation' Products

October 14, 2010 12:32 pm | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., Oct. 14 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today warned eight companies that their over-the-counter (OTC) chelation products are unapproved drugs and devices and that it is a violation of federal law to make unproven claims about these...

TOPICS:

New Survey Highlights Immediate Need for Anesthesia Information Management Systems

October 14, 2010 12:31 pm | by Bio-Medicine.Org | Comments

ATLANTA, Oct. 14 /- A new survey highlights the need for Anesthesia Information Management Systems (AIMS) with a full 91 percent of respondents indicating that access to day-of-surgery data is Extremely Important or Important to optimally manage their anesthesia department.  More...

TOPICS:

The AACR Congratulates Its Members Elected to the Institute of Medicine

October 14, 2010 11:32 am | by AACR | Comments

PHILADELPHIA — The American Association for Cancer Research congratulates 12 of its members on their election into the Institute of Medicine. They are among 65 new members and five foreign associates recently elected.

TOPICS:

Triple-mode graphene-based transistors show potential

October 14, 2010 10:39 am | by I-Micronews | Comments

Rice researchers introduce graphene-based amplifiers

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading